The Nrf2 pathway is of high medical interest due to its druggable nature, and Nrf2 inducers have been tested in clinical trials for cancer chemoprevention, chronic kidney disease, neurodegenerative diseases, and diabetes [13]. This evidence concerns the gene NFE2L2 and chronic kidney disease.